• US: +1-408-610-2300
  • Toll Free: +1-866-831-4085
  • Login / Register
  • Home
  • » Healthcare
  • » Head and Neck Cancer Treatment Market Size, 2017 | Industry Report
Head and Neck Cancer Treatment Market Size, 2017 | Industry Report

Head and Neck Cancer Treatment Industry 2017 Market Research Report

Report ID: MN17614895  |  Published: July 2017  |  No of Pages: 117
Format: Electronic (PDF)  |  Industry: Healthcare  |  Publisher: QY Research

The Head and Neck Cancer is a cluster of cancers that are initiated in the mouth cavity, oral cavity, salivary glands, lip, larynx, pharynx, nasal, and paranasal sinuses. It has been marked that maximum rates of Head & Neck Cancer arise from the squamous cell carcinomas in the epithelium of the various parts of head and neck. The Head & Neck Cancer comprises various symptoms that include difficulty in swallowing, change in voice, a sore in throat that persists, bleeding from mouth, weight loss, ulcers, unusual breathing, formations of lumps in the mouth or lips, etc.

There are various risk factors that are associated with Head & Neck Cancer such as excessive alcohol intake, tobacco consumption, infection from Human papillomavirus, exposure to high dosages of radiation therapy, and so on. The factors that propel the growth of the global Head & Neck Cancer Market include mounting geriatric population, increasing incidences of Head & Neck Cancer all over the globe, disposable income, and government initiatives for sophisticated healthcare aspects.

On the other hand, there are also factors that hinder the growth of Head & Neck Cancer Market including patent expiry of current drugs, side effects post treatment, difficulty in diagnosis, and the high expenditure on the cancer therapy. The global Head & Neck Cancer Market has been classified on the basis of type, stages, diagnostic method, treatment, end–user, and geography. On the basis of type, the global Head & Neck Cancer Market size constitutes nasal cavity and paranasal sinus cancer, nasopharyngeal cancer, laryngeal and hypo pharyngeal cancer, oral and oropharyngeal cancer, and salivary gland cancer. During the forecast period oral cancer is expected to account for the largest share in the global Head & Neck Cancer Market.

On the basis of Head & Neck Cancer stage, the global Head & Neck Cancer Market size comprises stage 0, stage I, stage II, stage III, and stage IV. Cancer staging is an important aspect as it guides the doctors to categorize the approach of treatment and also to conclude the spread of cancer.

On the basis of diagnostic method, the global Head & Neck Cancer Market size constitutes bioscopy screening tests, blood tests, dental diagnostic method, imaging diagnostic equipment, and endoscopy screening equipment. The imaging diagnostic equipment sector can be further classified as MRI, X-rays, CT scan, ultrasound, and PET. On the basis of treatment, the global Head & Neck Cancer Market size covers surgery, chemotherapy, radiation therapy, external radiation therapy, internal radiation therapy, and targeted therapy. During the forecast period surgery is estimated to dominate the treatment sector. Radiation therapy is followed by surgery owing to its utility in inhibition and reappearance of cancer.

On the basis of end-user, the global Head & Neck Cancer Market size gives hospitals, specialty clinics, and ambulatory surgical centres. The hospitals are anticipated to hold the largest share in the global Head & Neck Cancer Market. On the basis of geography, the global Head & Neck Cancer Market size gives North America, Europe, Asia Pacific, and Africa. In 2014, the North American market accounted for the largest market share of Head & Neck Cancer owing to the increasing aging population subsequently increasing the frequency of chronic diseases associated with Head & Neck Cancer. Some of the prominent players that fuel the growth of the global Head & Neck Cancer Market include Siemens Healthcare, AdDent, Inc., Varian Medical Systems, Philips Healthcare, GE Healthcare, and Identafi.

Market Segment:

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Head and Neck Cancer Treatment in these regions, from 2012 to 2022 (forecast), covering
• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Head and Neck Cancer Treatment market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
• Bristol-Myers Squibb
• Eli Lilly
• Merck
• Pfizer
• Amgen
• Dr. Reddy's Laboratories
• GlaxoSmithKline
• Mylan
• Sun Pharmaceutical Industries
• Takeda Pharmaceuticals
• Teva Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
• Oral Cavity Cancer
• Laryngeal Cancer
• Pharyngeal Cancer
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Head and Neck Cancer Treatment for each application, including
• Hospitals
• Clinics
• Others

What questions do you have? Get quick response from our industry experts. Request More information
Key questions answered in the report include
key questions
We also offers customization on reports based on specific client requirement.
Request for Customization

Choose License Type

Research Assistance

Ryan Manuel
Ryan Manuel

Research Support Specialist, USA

  1. Phone: +1-408-610-2300
  2. Toll Free: +1-866-831-4085
  3. Email: [email protected]
  • World's largest premium report database
  • Transparent pre & post sale customer engagement model
  • Unparalleled flexibility in terms of rendering services
  • Safe & secure web experience
  • 24*5 Research support service
  • 100% Secure Payments
  • Our Promise
  • 100% Service Assurance
  • Market Monitoring
  • Service Flexibility
  • 24X5 Care available